Detection of SARS-CoV-2 Antibodies in Diagnosis and Treatment of COVID-19, An Issue of the Clinics in Laboratory Medicine, E-Book
Key Features
-
Contains 9 relevant, practice-oriented topics including disease-specific alterations in the cellular bases of the humoral immune response in COVID-19; coronavirus antigens as targets of antibody responses; approaches for SARS-CoV-2 antibody testing in a reference lab; use of IgM, IgA, and IgG in treatment and prognosis of patients with COVID-19; performance of lateral flow assays for COVID-19 serology; and more.
-
Provides in-depth clinical reviews on detection of SARS-CoV-2 antibodies in diagnosis and treatment of COVID-19, offering actionable insights for clinical practice.
-
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
ISBN | 9780323835879 |
---|---|
Product Format | Ebook |
Publication Date | 2022 |
Author Information | Edited by Daimon P. Simmons, MD PhD, Instructor in Pathology, Brigham and Women's Hospital and,Harvard Medical School and Peter H. Schur, MD, Co-Director, Lupus Center, Professor, Harvard Medical School, Brigham and Women's Hospital |
Table of Content | Severe Acute Respiratory Syndrome Coronavirus 2 Serology Testing - A Laboratory Primer Performance Characteristics of High-Throughput Serologic Assays for Severe Acute Respiratory Syndrome Coronavirus 2 with Food and Drug Administration Emergency Use Authorization: A Review Performance Evaluation of Lateral Flow Assays for Coronavirus Disease-19 Serology Alternative Methods to Detect Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies Suboptimal Humoral Immunity in Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Viral Variant Generation Antibody Dynamics and Durability in Coronavirus Disease-19 Severe Acute Respiratory Syndrome Coronavirus 2 Antigens as Targets of Antibody Responses Vaccine-Induced Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and the Path to Accelerating Development (Determining a Correlate of Protection) |
Publication Date | 23-02-2022 |
Pages | 240 |
deltacomm1code | Electronic Book |